By using this site you agree to our use of cookies. Please refer to our privacy policy for more information. Close
Home
› Best Practices
Philippines Anti-Money Laundering Act of 2001 – An Overview and Summary of Requirements
- By: Staff Editor
- Date: August 08, 2013
Compliance Webinars | Virtual Seminars for Professionals
The Philippines’ government enacted this anti-money laundering law in 2001 and it defines the crime of money laundering, details penalties for violating these rules and also provides guidelines for financial institutions on how to ensure compliance with the law. The Bangko Sentral ng Pilipinas (BSP) oversees the enforcement of this Act.
1. Requirements for preventing money laundering
Customer Identification
- Covered institutions should establish and record the true identity of its clients based on official documents.
- They should maintain a system of verifying the true identity of their clients
- In case of corporate clients, they should require a system of verifying their
- Legal existence
- Organizational structure
- Authority and identification of all persons purporting to act on their behalf.
- The provisions of existing laws to the contrary notwithstanding, anonymous accounts, accounts under fictitious names, and all other similar accounts should be absolutely prohibited.
- Peso and foreign currency non-checking numbered accounts should be allowed.
- The BSP can conduct annual testing to determine the existence and true identity of the owners of such accounts.
Recordkeeping
- All records of all transactions of covered institutions should be maintained and safely stored for 5 years from the dates of transactions.
- With respect to closed accounts, the records on customer identification, account files and business correspondence, should be preserved and safely stored for at least five years from the dates when they were closed.
Reporting of Covered Transactions
- Covered institutions should report to the BSP’s Anti Money Laundering Council (AMLC) all covered transactions within five working days from occurrence.
- When reporting covered transactions to the AMLC, covered institutions and their officers, employees, representatives, agents, advisors, consultants or associates should not communicate, directly or indirectly, to any person the fact that a covered transaction report was made, its contents or any related information.
2. Authority to Freeze – If the AMLC determines that any deposit or similar account is related to unlawful activity, it can issue a freeze order to be effective immediately.
3. Authority to Inquire into Bank Deposits - The AMLC can inquire into or examine any particular deposit or investment with any banking institution or non-bank financial institution upon order of any competent court in cases of violation of this Act
4. Forfeiture Provisions
- Revised Rules of Court on Civil forfeiture should be applied
- The offender should submit a verified petition to declare segregation or exclusion of the legitimate property from the corresponding monetary instrument or property.
- If any particular monetary instrument or property has been altered in value, the convicted offender should pay an amount equal to the said value.
5. Mutual Assistance among States
- AMLC can execute or refuse the request for assistance from a foreign state.
- AMLC has the following powers to act on the request from a foreign state:
- Track down, freeze, restrain and seize assets alleged to be proceeds of any unlawful activity
- Give information needed by the foreign State
- Apply for an order of forfeiture of any monetary instrument or property in the court
- AMLC can obtain assistance from foreign states in all the above.
- The AMLC can refuse request for assistance where it contravenes any provision of the Constitution or the execution of a request is likely to prejudice the national interest of the Philippines.
6. Penal Provisions
Penalties for the Crime of Money Laundering
|
Money Laundering Offence
|
Penalty
|
|
Any person knowing that any monetary instrument or property represents, involves, or relates to, the proceeds of any unlawful activity, transacts or attempts to transact said monetary instrument or property.
|
7-17 years imprisonment
Fine of not less than 3 million Php but not more than twice the value of the monetary instrument or property
|
|
Any person knowing that any monetary instrument or property involves the proceeds of any unlawful activity, performs or fails to perform any act as a result of which he facilitates the offense of money laundering
|
4-7 years imprisonment
Fine of not less than 1 million Php but not more than 3 million Php
|
|
Any person knowing that any monetary instrument or property is required under this Act to be disclosed and filed with the Anti-Money Laundering Council (AMLC), fails to do so.
|
6 months -4 years imprisonment
Fine of not less than 100,000 Php but not more than 500,000 Php or both
|
Penalties for Failure to Keep Records:
- 6 months to 1 year imprisonment
- Fine of not less than 100,000 Php but not more than 500,000 Php or both
Penalties for Malicious Reporting.
- 6 months to 4 years imprisonment
- Fine of not less than 100,000 Php but not more than 500,000 Php
Penalties for Breach of Confidentiality.
- 3-8 years of imprisonment
- Fine of not less than 500,000 Php but not more than 1 million Php
Trending Compliance Trainings

Sterile Filtration of Pharmaceutical Products - Validation and Regulatory Requirements
By - Roger Cowan
On Demand Access Anytime
By - Roger Cowan
On Demand Access Anytime

FFIEC BSA/AML Examination Manual: What Compliance Officers Really Need to Know?
By - Doug Keipper
On Demand Access Anytime
By - Doug Keipper
On Demand Access Anytime

Technical Writing for the Pharmaceutical, Medical Device and Biotech Industries
By - Joy McElroy
On Demand Access Anytime
By - Joy McElroy
On Demand Access Anytime

Trial Master File and Clinical Data Management Regulated by FDA
By - Carolyn Troiano
On Demand Access Anytime
By - Carolyn Troiano
On Demand Access Anytime

Good Documentation Practice and Record Keeping Regulations (FDA & EMA)
By - Dr. Afsaneh Motamed Khorasani
On Demand Access Anytime
By - Dr. Afsaneh Motamed Khorasani
On Demand Access Anytime



Understanding and Preparing for FDA Pharmaceutical Inspections
By - Michael Ferrante
On Demand Access Anytime
By - Michael Ferrante
On Demand Access Anytime


Best Sellers
- Add to Cart
- Add to Cart
- Add to Cart
- Add to Cart
- Add to Cart
- Add to Cart
- Add to Cart
- Add to Cart
-
By: Miles HutchinsonAdd to CartPrice: $249
- Add to Cart
- Add to Cart
- Add to Cart
- Add to Cart
- Add to Cart
- Add to Cart
-
Add to CartSan Francisco, CA | Aug 6-7, 2020
-
Add to CartVirtual Seminar | Jul 16-17, 2020
-
Add to CartVirtual Seminar | Jun 18-19, 2020
-
Add to CartLos Angeles, CA | Aug 20-21, 2020
-
Add to CartVirtual Seminar | Jul 16-17, 2020
-
Add to CartVirtual Seminar | Jun 25-26, 2020
-
Add to CartVirtual Seminar | Jun 10, 2020
-
Add to CartVirtual Seminar | Jun 3-4, 2020
-
Add to CartVirtual Seminar | Jul 6-7, 2020
-
Add to CartSan Francisco, CA | Oct 22-23, 2020
-
Add to CartVirtual Seminar | Jul 9-10, 2020
-
Add to CartVirtual Seminar | Jun 3-4, 2020
-
Add to CartVirtual Seminar | June 3-4, 2020
-
Add to CartMiami, FL | Jul 29-31, 2020
-
Add to CartVirtual Seminar | Jun 17, 2020
-
Provider: ANSIAdd to CartPrice: $142
- Add to Cart
- Add to Cart
- Add to Cart
-
Provider: ANSIAdd to CartPrice: $120
-
Provider: ANSIAdd to CartPrice: $250
-
Provider: SEPTAdd to CartPrice: $299
- Add to Cart
-
Provider: Quality-Control-PlanAdd to CartPrice: $37
- Add to Cart
-
Provider: At-PQCAdd to CartPrice: $397
- Add to Cart
- Add to Cart
- Add to Cart
- Add to Cart
You Recently Viewed







